Thirumalai Chemicals Ltd
- Market Cap ₹ 3,252 Cr.
- Current Price ₹ 318
- High / Low ₹ 363 / 191
- Stock P/E 58.1
- Book Value ₹ 107
- Dividend Yield 0.31 %
- ROCE 7.45 %
- ROE 3.73 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 19.3%
Cons
- Company has a low return on equity of 11.5% over last 3 years.
- Contingent liabilities of Rs.1,128 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of Nifty Microcap 250 BSE Allcap BSE Commodities BSE SmallCap Nifty Total Market
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,145 | 1,034 | 923 | 777 | 857 | 1,012 | 994 | 865 | 857 | 1,438 | 1,847 | 1,987 | 2,043 | |
1,044 | 988 | 879 | 692 | 725 | 783 | 840 | 791 | 668 | 1,198 | 1,672 | 1,899 | 1,920 | |
Operating Profit | 101 | 45 | 44 | 84 | 133 | 229 | 155 | 74 | 190 | 240 | 176 | 88 | 122 |
OPM % | 9% | 4% | 5% | 11% | 15% | 23% | 16% | 9% | 22% | 17% | 10% | 4% | 6% |
8 | 16 | 16 | 12 | 8 | 10 | 14 | 22 | 9 | 15 | 44 | 38 | 21 | |
Interest | 52 | 45 | 33 | 21 | 15 | 11 | 11 | 16 | 19 | 18 | 34 | 44 | 34 |
Depreciation | 13 | 12 | 7 | 11 | 14 | 10 | 15 | 21 | 25 | 32 | 30 | 34 | 34 |
Profit before tax | 44 | 3 | 20 | 64 | 112 | 218 | 143 | 60 | 154 | 205 | 156 | 48 | 76 |
Tax % | 37% | -3% | 27% | 33% | 34% | 34% | 33% | 31% | 24% | 26% | 24% | 25% | |
28 | 4 | 14 | 43 | 74 | 144 | 96 | 41 | 118 | 152 | 120 | 36 | 56 | |
EPS in Rs | 2.71 | 0.35 | 1.39 | 4.17 | 7.24 | 14.06 | 9.38 | 3.99 | 11.49 | 14.88 | 11.67 | 3.55 | 5.47 |
Dividend Payout % | 28% | 0% | 29% | 24% | 26% | 14% | 21% | 0% | 19% | 17% | 13% | 28% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 15% |
3 Years: | 32% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 26% |
5 Years: | -18% |
3 Years: | -32% |
TTM: | -28% |
Stock Price CAGR | |
---|---|
10 Years: | 41% |
5 Years: | 38% |
3 Years: | 10% |
1 Year: | 63% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 12% |
3 Years: | 11% |
Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 128 | 132 | 141 | 174 | 357 | 504 | 572 | 545 | 714 | 858 | 952 | 974 | 1,081 |
251 | 162 | 83 | 28 | 0 | 0 | 50 | 139 | 125 | 105 | 332 | 189 | 260 | |
277 | 290 | 183 | 178 | 285 | 142 | 291 | 294 | 269 | 517 | 569 | 560 | 559 | |
Total Liabilities | 666 | 594 | 417 | 390 | 652 | 656 | 923 | 988 | 1,119 | 1,490 | 1,864 | 1,733 | 1,910 |
92 | 77 | 74 | 79 | 146 | 147 | 171 | 329 | 317 | 416 | 411 | 408 | 396 | |
CWIP | 1 | 3 | 0 | 6 | 9 | 39 | 159 | 71 | 108 | 6 | 12 | 5 | 5 |
Investments | 33 | 33 | 32 | 32 | 79 | 173 | 219 | 119 | 210 | 418 | 538 | 657 | 770 |
541 | 481 | 310 | 273 | 417 | 298 | 374 | 470 | 483 | 650 | 903 | 663 | 738 | |
Total Assets | 666 | 594 | 417 | 390 | 652 | 656 | 923 | 988 | 1,119 | 1,490 | 1,864 | 1,733 | 1,910 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
21 | 127 | 106 | 114 | 97 | 79 | 161 | 119 | 181 | 268 | 17 | 129 | |
6 | 20 | -1 | -21 | -42 | -35 | -165 | -24 | -143 | -217 | -297 | 200 | |
-31 | -139 | -112 | -94 | -43 | -34 | 14 | 47 | -36 | -69 | 166 | -214 | |
Net Cash Flow | -5 | 8 | -8 | -0 | 12 | 10 | 9 | 142 | 2 | -17 | -114 | 115 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 81 | 67 | 54 | 52 | 48 | 26 | 29 | 27 | 21 | 24 | 18 | 30 |
Inventory Days | 75 | 80 | 34 | 38 | 83 | 69 | 95 | 76 | 77 | 79 | 83 | 54 |
Days Payable | 92 | 61 | 33 | 92 | 144 | 43 | 121 | 126 | 123 | 147 | 130 | 117 |
Cash Conversion Cycle | 63 | 86 | 55 | -2 | -13 | 51 | 3 | -22 | -25 | -44 | -28 | -32 |
Working Capital Days | 58 | 40 | 25 | 17 | 13 | 36 | 7 | -1 | -8 | -21 | 50 | 1 |
ROCE % | 26% | 13% | 19% | 38% | 44% | 52% | 27% | 11% | 22% | 24% | 17% | 7% |
Documents
Announcements
-
Material Event
1d - Equity infusion of USD 45 Mn and INR 200 Cr loan.
- Reg. 33(3) Of SEBI (LODR) Regulations, 2015 Un-Audited Financial Results For The Quarter/Half-Year Ended September 30, 2024. 29 Oct
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 16 Oct
-
Board Meeting Intimation for Under Regulation 29 Of SEBI (LODR) Regulations, 2015--Board Meeting To Consider Un-Audited Financial Results For The Quarter/Half Year Ended September 30, 2024.
9 Oct - Board meeting to consider un-audited financial results.
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
9 Oct - Information on stop transfer of lost share certificates.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Products